Recombine

Venture-backed company · Stage unknown
Rounds on record
1
Latest round
Feb 10, 2014
Form D equity offering
Latest round size
$3.6M
More
Ask DFX about thisView relationshipsFinancing historyInvestorsOwnership and outcomes
As of · the latest observation of this company; each round carries its own date

What matters now

  1. Acquired
    observed

    Acquired by Cooper Genomics (seen on or before Sep 12, 2026).

    seen on or before Sep 12, 2026 · A later owner ends or changes the venture chapter: new decision makers, new lenders, returns for the investors on record.

    Factpress and portfolio pagesFor Investors, acquirers, lenders, service providersOwnership and outcomes →
  2. 1 investor
    named

    1 investor on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
Drawing the relationship network…

Facts

Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1

Financing history

1 round
  1. Feb 10, 2014
    Form D equity offering · $3.6M (form d sold)
    Firstmark Capital, LLC via Mathias Turck
    Fact Form D · “Recombine, Inc. Form D, first filed 2014-02-25”

Investors on record

2 edges

Ownership and outcomes

1 on record, from the private equity graph and exit reports
Outcome stated by investors

Acquired by Cooper Genomics, as 1 of 1 firm portfolio page states it.

Date basis: the firm’s page was read Sep 16, 2026; DFX first saw this outcome Sep 16, 2026. This is when the page said it, not when the deal happened.

Evidence: 1 listingeach firm's own card, as read
  • Acquired by Cooper Genomics · already an investor on record
    seen on or before Sep 12, 20261 venture investor on record at exitFactfirstmark.com
    “Recombine: acquired by Cooper Genomics on or before 2026-09-12 (no date published), per Firstmark Capital, LLC's portfolio page”

Credit relationships

none on record
No lender position matched to this company.

People

0 officers, 0 directors
No officer or director on record.

Timeline

1 event
  1. seen on or beforeSep 12, 2026
    Recombine: acquired by Cooper Genomics on or before 2026-09-12 (no date published), per Firstmark Capital, LLC's portfolio page
    Acquired Fact Firm website

Evidence

2 observations
Every observation on this company
  • Listed on portfolio page: Firstmark Capital, LLC Sep 16, 2026 Fact Firm website
  • Listed on portfolio page: Firstmark Capital, LLC Sep 12, 2026 Fact Firm website

Record history

2 identity changes, 2 dated events on the change ledger, latest event first
  • Event retracted
    2026-09-30
  • Portfolio entry removed
    2026-09-30source on record
  • Renamed
    2026-09-13

+1 more change on this record's ledger

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.